Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does COCHLIOBOLUS SATIVUS Cause Injection site dryness? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Injection site dryness have been filed in association with COCHLIOBOLUS SATIVUS (BIPOLARIS SOROKINIANA). This represents 16.7% of all adverse event reports for COCHLIOBOLUS SATIVUS.

6
Reports of Injection site dryness with COCHLIOBOLUS SATIVUS
16.7%
of all COCHLIOBOLUS SATIVUS reports
0
Deaths
0
Hospitalizations

How Dangerous Is Injection site dryness From COCHLIOBOLUS SATIVUS?

Of the 6 reports.

Is Injection site dryness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for COCHLIOBOLUS SATIVUS. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does COCHLIOBOLUS SATIVUS Cause?

Local reaction (5)

What Other Drugs Cause Injection site dryness?

DUPILUMAB (320) ETANERCEPT (37) ADALIMUMAB (31) SARILUMAB (29) BELIMUMAB (21) PEGINTERFERON BETA-1A (21) TREPROSTINIL (16) ALIROCUMAB (14) GLATIRAMER (13) INTERFERON BETA-1A (13)

Related Pages

COCHLIOBOLUS SATIVUS Full Profile All Injection site dryness Reports All Drugs Causing Injection site dryness COCHLIOBOLUS SATIVUS Demographics